EP1139913A4 - Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants - Google Patents

Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants

Info

Publication number: EP1139913A4
Authority: EP; European Patent Office
Prior art keywords: anabolisers; nociceptives; anxiolytics; formulations; composition
Prior art date: 1999-01-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00904212A

Other languages

German (de)

English (en)

Other versions

EP1139913A1 (fr

Inventor

Jonathan W Nyce

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

East Carolina University

Original Assignee

East Carolina University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-05

Filing date

2000-01-05

Publication date

2002-09-11

2000-01-05 Application filed by East Carolina University filed Critical East Carolina University

2001-10-10 Publication of EP1139913A1 publication Critical patent/EP1139913A1/fr

2002-09-11 Publication of EP1139913A4 publication Critical patent/EP1139913A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Child & Adolescent Psychology (AREA)

EP00904212A 1999-01-05 2000-01-05 Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants Withdrawn EP1139913A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11477399P	1999-01-05	1999-01-05
US114773P		1999-01-05
PCT/US2000/000180 WO2000040172A1 (fr)	1999-01-05	2000-01-05	Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants

Publications (2)

Publication Number	Publication Date
EP1139913A1 EP1139913A1 (fr)	2001-10-10
EP1139913A4 true EP1139913A4 (fr)	2002-09-11

Family

ID=22357344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00904212A Withdrawn EP1139913A4 (fr)	1999-01-05	2000-01-05	Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants

Country Status (9)

Country	Link
EP (1)	EP1139913A4 (fr)
JP (1)	JP2003523933A (fr)
KR (1)	KR20010089782A (fr)
CN (1)	CN1354640A (fr)
AU (1)	AU2600000A (fr)
BR (1)	BR0007397A (fr)
CA (1)	CA2356368A1 (fr)
IL (1)	IL143644A0 (fr)
WO (1)	WO2000040172A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000007566A1 (fr) *	1998-08-03	2000-02-17	Epigenesis Pharmaceuticals, Inc.	Nouvel agent analgesique, anti-inflammatoire et cicatrisant
KR100348888B1 (en) *	2001-12-11	2002-08-14	Chang Eun Jung	Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof
WO2009051609A1 (fr)	2007-10-19	2009-04-23	Pardee Joel D	Traitement d'amélioration métabolique

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0388827A1 (fr) *	1989-03-22	1990-09-26	BIORESEARCH S.p.A.	Utilisation des acides 5-méthyltétrahydrofolique, 5-formyltétrahydrofolique ainsi que de leurs sels pharmaceutiquement acceptables pour la préparation de compositions pharmaceutiques sous forme à libération contrôlée dans la thérapie des troubles organiques mentaux, et les compositions pharmaceutiques correspondantes
WO1996025935A1 (fr) *	1995-02-24	1996-08-29	East Carolina University	Procede de traitement de la depletion de l'adenosine
WO1997027764A1 (fr) *	1996-01-31	1997-08-07	South Alabama Medical Science Foundation	Preparations alimentaires et vitaminees contenant l'isomere naturel de folates reduits
WO1998019690A1 (fr) *	1996-11-06	1998-05-14	Bristol-Myers Squibb Company	Methode de traitement de la maladie d'alzheimer
WO2000007566A1 (fr) *	1998-08-03	2000-02-17	Epigenesis Pharmaceuticals, Inc.	Nouvel agent analgesique, anti-inflammatoire et cicatrisant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5767278A (en) *	1995-10-06	1998-06-16	Geron Corporation	Telomerase inhibitors

2000
- 2000-01-05 KR KR1020017008574A patent/KR20010089782A/ko not_active Withdrawn
- 2000-01-05 JP JP2000591931A patent/JP2003523933A/ja not_active Withdrawn
- 2000-01-05 WO PCT/US2000/000180 patent/WO2000040172A1/fr not_active Ceased
- 2000-01-05 CN CN00802582A patent/CN1354640A/zh active Pending
- 2000-01-05 AU AU26000/00A patent/AU2600000A/en not_active Abandoned
- 2000-01-05 IL IL14364400A patent/IL143644A0/xx unknown
- 2000-01-05 EP EP00904212A patent/EP1139913A4/fr not_active Withdrawn
- 2000-01-05 CA CA002356368A patent/CA2356368A1/fr not_active Abandoned
- 2000-01-05 BR BR0007397-0A patent/BR0007397A/pt not_active IP Right Cessation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0388827A1 (fr) *	1989-03-22	1990-09-26	BIORESEARCH S.p.A.	Utilisation des acides 5-méthyltétrahydrofolique, 5-formyltétrahydrofolique ainsi que de leurs sels pharmaceutiquement acceptables pour la préparation de compositions pharmaceutiques sous forme à libération contrôlée dans la thérapie des troubles organiques mentaux, et les compositions pharmaceutiques correspondantes
WO1996025935A1 (fr) *	1995-02-24	1996-08-29	East Carolina University	Procede de traitement de la depletion de l'adenosine
WO1997027764A1 (fr) *	1996-01-31	1997-08-07	South Alabama Medical Science Foundation	Preparations alimentaires et vitaminees contenant l'isomere naturel de folates reduits
WO1998019690A1 (fr) *	1996-11-06	1998-05-14	Bristol-Myers Squibb Company	Methode de traitement de la maladie d'alzheimer
WO2000007566A1 (fr) *	1998-08-03	2000-02-17	Epigenesis Pharmaceuticals, Inc.	Nouvel agent analgesique, anti-inflammatoire et cicatrisant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FRENIA MAUREEN L ET AL: "Methanol inhalation toxicity.", ANNALS OF EMERGENCY MEDICINE, vol. 22, no. 12, 1993, pages 1919 - 1923, XP001080384, ISSN: 0196-0644 *
See also references of WO0040172A1 *

Also Published As

Publication number	Publication date
JP2003523933A (ja)	2003-08-12
CN1354640A (zh)	2002-06-19
WO2000040172A1 (fr)	2000-07-13
CA2356368A1 (fr)	2000-07-13
AU2600000A (en)	2000-07-24
KR20010089782A (ko)	2001-10-08
EP1139913A1 (fr)	2001-10-10
IL143644A0 (en)	2002-04-21
WO2000040172B1 (fr)	2000-11-02
BR0007397A (pt)	2001-10-30

Publication	Publication Date	Title
NO20021116D0 (no)	2002-03-06	Ny sammensetning
MA25688A1 (fr)	2003-04-01	2-thio-3, 5-dicyano-4-aryl-6-aminopyridines substituees et leur utilisation.
ATE277111T1 (de)	2004-10-15	Farbstabile superabsorbierende polymerzusammensetzung
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
DE60045324D1 (de)	2011-01-13	Impfstoffzusammensetzung
ITMI991754A0 (it)	1999-08-04	Composizioni cosmetiche
DE60031954D1 (de)	2007-01-04	Lippenstiftzusammensetzung
DE60021018D1 (de)	2005-08-04	Polymerzusammensetzungen
DE60014105D1 (de)	2004-10-28	Verbesserte herbizidzusammensetzunen
NO20021115L (no)	2002-04-30	Ny sammensetning
DE60010547D1 (de)	2004-06-17	Vernetzbare Fluoropolyetherzusammensetzungen
PT1086701E (pt)	2006-05-31	Composicao laxante contendo simeticone
DE60015460D1 (de)	2004-12-09	Polymerzusammensetzungen
FR2807052B1 (fr)	2003-08-15	Compositions silico-acryliques, leur procede de preparation et leur utilisation
IS6398A (is)	2002-05-27	Lyfjablöndur
NO20020319D0 (no)	2002-01-21	Oftalmisk sammensetning
DE69925167D1 (de)	2005-06-09	Hochwitterungsbeständige pulverlackzusammensetzung
DE60035436D1 (de)	2007-08-16	Aerosolzusammensetzung
HUP0203275A3 (en)	2003-11-28	1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
ATE288940T1 (de)	2005-02-15	Polymerzusammensetzung
FR2829694B1 (fr)	2003-12-05	Nouvelles compositions cosmetiques comprenant des extraits vegetaux et leur utilisation comme agent antiradicalaire
DE60114039D1 (de)	2006-02-23	Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
FIU990494U0 (fi)	1999-12-03	Uusi koostumus
DE60020682D1 (de)	2005-07-14	Resorcinenthaltende zusammensetzung
AR025731A1 (es)	2002-12-11	"ditiepino [6,5-b] piridinas benzo-fusionadas y composiciones y metodos relacionados"

Legal Events

Date	Code	Title	Description
2001-08-24	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-10-10	17P	Request for examination filed	Effective date: 20010625
2001-10-10	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-09-11	A4	Supplementary search report drawn up and despatched	Effective date: 20020726
2002-09-11	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-09-11	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/519 A, 7A 61K 31/5685 B, 7A 61K 31/569 B, 7A 61K 45/06 B, 7A 61P 1/08 B, 7A 61P 25/22 B
2003-03-26	17Q	First examination report despatched	Effective date: 20030210
2004-01-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-02-25	18D	Application deemed to be withdrawn	Effective date: 20030821